戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 veness to treatment with levodopa-carbidopa (Sinemet).
2 ecrease in adverse responses seen at the mid-Sinemet (250 mg levodopa-25 mg carbidopa) dose level.
3                              The response to Sinemet did not change after intracerebroventricular veh
4         The present study has evaluated GDNF-Sinemet interactions in parkinsonian rhesus monkeys.
5                                              Sinemet is currently the most widely used drug for treat
6 nation with a suprathreshold dose of L-DOPA (Sinemet(R)) in 22 patients with Parkinson's disease (16
7                         Adverse responses to Sinemet treatment alone in parkinsonian animals included
8                          Thus, combined GDNF-Sinemet treatment could be of therapeutic value in treat
9                                Combined GDNF-Sinemet treatment significantly reduced the occurrence o
10 ponse and by mitigating adverse responses to Sinemet treatment.
11                                Both GDNF and Sinemet, when given alone, significantly improved total

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。